Results for tag: "Nuthrax"

The NuThrax market is a subset of the larger Vaccines market, focusing on the development and distribution of a recombinant anthrax vaccine. This vaccine is designed to protect against anthrax, a potentially fatal bacterial infection caused by the bacterium Bacillus anthracis. The vaccine is administered in a series of three doses, and is approved for use in adults and children over the age of 18 months. The NuThrax market is a relatively small but growing sector of the Vaccines market. It is driven by the need for a safe and effective vaccine to protect against anthrax, as well as the increasing demand for vaccines in general. Companies in the NuThrax market include Emergent BioSolutions, GlaxoSmithKline, Pfizer, and Sanofi Pasteur. Show Less Read more